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ABSTRACT
The present study was aimed at evaluating antihyperglycemic and antihyperlipidemic activity of nuciferin and 
norcoclaurine constituents of N. nucifera seeds, a well-known medicinal plant. The alloxan (100 mg/kg b.w) induced 
diabetic rats (200-250 g) were divided into seven groups (n = 6). Group I; normal control, Group II; diabetic control, 
Group III; standard, Group lV-VII were fed with methanolic crude extracts (100, 200 mg/kg), nuciferin and norcoclaurine 
(10 mg/kg b.w.), received for 15 days in dose dependent manner. The study included different parameters; examination of 
oral glucose, fasting blood glucose, serum lipid profile and checking for body weight changes. In oral glucose examination, 
within 60 and 80 min of treatment, extracts, nuciferin and norcoclaurine significantly reduced blood glucose (p<0.05) 
and restored body weight in diabetic rats. Alloxan- induced diabetic rats showed 30-50% reduction of blood glucose 
level (p<0.05) and recovered 5-20% body weight at day 15 after ingestion of crude extracts (100-200 mg/kg b.w.); and 
nuciferin and norcoclaurine (each at 10 mg/kg b.w.). It also recovered significantly elevated biochemical parameters such 
as triglycerides (TG), low density lipoprotein (LDL), high density lipoprotein (HDL), total cholesterol (TC), serum urea and 
creatinine. Our findings indicated that N. nucifera seeds possess significant antihyperglycemic and antihyperlipidemic 
activity in diabetic rats.
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ABSTRAK
Penyelidikan ini bertujuan untuk menilai aktiviti antihiperglisemik dan antihiperlipidemik juzuk nusiferin dan  norkoklaurin 
biji N. nucifera, tumbuhan ubatan yang terkenal. Aloksan (100 mg/kg kW) tikus teraruh diabetis (200-250 g) dibahagikan 
kepada tujuh Kumpulan (n=6). Kumpulan I; kawalan biasa, Kumpulan II; kawalan diabetis, Kumpulan III; piawai, 
Kumpulan IV-VII diberi makan dengan ekstrak mentah metanolik (100, 200 mg/kg), nusiferin dan norkoklaurin (10 mg/
kg b.w.), menerima dos secara bersandar selama 15 hari. Kajian ini merangkumi parameter yang berbeza; pemeriksaan 
glukosa secara oral, glukosa darah puasa, profil lipid serum dan pemeriksaan perubahan berat badan. Dalam tempoh 60 
dan 80 min rawatan untuk pemeriksaan glukosa secara oral, ekstrak,  nusiferin dan norkoklaurin telah mengurangkan 
glukosa darah (p<0.05) dan memulihkan berat badan tikus diabetis. Aloksan - tikus teraruh diabetis menunjukkan 30-
50% pengurangan paras glukosa darah (p<0.05) dan mendapat kembali 5-20% berat badan pada hari ke-15 selepas 
ketakhadaman ekstrak mentah (100-200 mg/kg b.w.); serta nusiferin dan norkoklaurin (masing-masing pada 10 mg/kg 
b.w.). Ia juga dengan ketara mendapat kembali peningkatan parameter biokimia seperti trigliserida (TG), lipoprotein 
ketumpatan rendah (LDL), lipoprotein ketumpatan tinggi (HDL), jumlah kolesterol (TC), serum urea dan kreatinina. 
Keputusan kajian kami menunjukkan bahawa biji N. nucifera mempunyai aktiviti antihiperglisemik dan antihiperlipidemik 
yang penting dalam tikus diabetis. 
Kata kunci: Antihiperglisemik; antihiperlipidemik; norkoklaurin; nusiferin; N. nucifera
INTRODUCTION
Diabetes mellitus is known as one of the important causes 
of morbidity and mortality in the world. The frequency of 
diabetes according to WHO is about 150 million worldwide 
and this figure is estimated to increase up to 300 million 
by the year 2025 (Boyle et al. 2001). Modern medication 
used for the treatment of diabetes are often associated with 
side effects (Fowler 2007). Most of the thousand medicinal 
plants used universally for the traditional treatment of 
the disease. Antihyperglycemic activity of these plants 
was supported by investigational studies (Marlos et al. 
1995). However medicinal plants are important and act as 
alternative therapeutics. It has been shown that medicinal 
herbs potentially enhanced the immunity against various 
infections. About thirteen thousand plant species have 
been observed to have pathological and pharmacological 
properties (Kumar et al. 2010; Sindhu et al. 2011). The 
use of herbal remedies were claimed to be more effective 
and cheaper with minimal side effects (Haldar et al. 2010) 
than the use of synthetic medicines.
1518 
 Nelumbo nucifera (Nelumbonaceae) is a free floating 
plant which various parts have been claimed to possess 
medicinal values. The plant seeds, leaves and roots are taken 
for the treatment of fever, diarrhea, skin diseases as well as 
antiseptic and antispasmodics. Dried leaves were applied to 
sores, rheumatism, lumbago, sciatica and painful tumors. 
The leaves of this plant also act as analgesic, anesthetic, 
expectorant, vermifuge and sedative. The juice of leaves 
is used in ophthalmia, earache, toothache to relieve pains 
in gout, inflammation and leprosy (Sridhar et al. 2007). N. 
nucifera is used in the prevention of miscarriages and as 
an antihemorrhagic agent especially for excess menstrual 
bleeding (Huang et al. 2010). In this study, we investigated 
the antihyperglycemic and antihyperlipidemic activity of 
Nelumbo nucifera constituents in diabetic rats.
MATERIALS AND METHODS
PLANT MATERIAL
Mature and fully dried seeds of Nelumbo nucifera were 
obtained from a local supplier (public market) in Bannu 
city. Further taxonomic identification was made by Prof. 
Abdur Rehman, Govt. Post Graduate College Bannu, 
KPK, Pakistan. A specimen (BG-201) has been submitted 
at the University of Science and Technology, Bannu, KPK 
Pakistan herbarium. 
EXTRACTION AND ISOLATION OF COMPOUNDS
N. nucifera seeds (8 kg) were refluxed with MeOH and 
evaporated to yield gummy residue (400 g). The crude 
methanolic extract was suspended in water and pooled 
with 0.5 N H2SO4 (pH1.5) followed by extraction with 
CHCl3 (3 × 2 L) to afford acidic and non-acidic mixtures. 
The acidic aqueous solution was basified (pH8-10) by 
10% KOH (aq) and extracted with CHCl3 to yield 15 g of 
alkaloidal mixture (NA). NA was fractionated on silica 
gel column with elution of n-hexane, EtOAc and MeOH 
solvent mixtures. The resulted fractions (NA1-NA9) were 
put into repeated flash column chromatography using 
solvent system n-hexane: acetone: diethyl amine (9:1: 
2 drops) to furnish nuciferin (1) and norcoclaurine (2), 
respectively (Figure 3). 
CHARACTERIZATION OF COMPOUNDS
Infrared (IR) spectra were recorded on a SHIMADZU-FTIR 
8101 M spectrophotometer using KBr discs. For nuclear 
magnetic resonance (NMR), 1H and 13C, Distortionless 
Enhancement by Polarization Transfer (DEPT) and 
Heteronuclear Single Quantum Coherence (HSQC) NMR 
spectra were recorded on Brucker Avance 400 MHz. The 
chemical shift (δ) values are given in parts per million 
(ppm) with coupling constant J in Hertz. Electron impact 
mass spectra (EI-MS) were recorded on a HP5989B mass 
spectrometer. Thin layer chromatography was carried out on 
pre coated silicagel GF254 (Merck, Germany) and spots were 
sprayed with dragendorff’s reagent. Flash chromatography 
was performed using silica gel 70-230 mesh (Merck).
Nuciferin Colourless solid; mp 240-242ºC, M.F= 
C19H21NO2, EI-MS (m/z), [M] + 295.1530. The data was 
in complete agreement with that for nuciferin (Ma et al. 
2014).
Norcoclaurine (1) Colourless prisms; mp 239-242ºC, M.F= 
C16H17NO3, EI-MS (m/z), [M] + 269.1392. The data was in 
close resemblance with that for norcoclaurine in literature 
(Mukherjee et al. 2009).
CHEMICALS
Glucometer (Roche Diagnostics Corporation, USA). 
Glebenclamide and Alloxan monohydrate (Sigma 
Germany). Methanol (Merck). Sodium citrate buffer.
ANIMALS
Forty two adult Sprague dawley strains of albino rats 
(200-250 g, b.w.) were provided by the National Institute 
of Health, Islamabad. The animals were maintained at 
a constant temperature (24±1°C) on a 12 h light/dark 
cycle with free access to food and water. Before starting 
the experiment, the animals went through an adjustment 
period of 20 days.
EXPERIMENTAL INDUCTION OF DIABETES
Diabetes was induced in the experimental animals by the 
intraperitoneal injection of alloxan monohydrate (100 mg/
kg). Alloxan treated rats received 5% glucose instead of 
water for 28 h after diabetes induction in order to reduce 
death due to hyperglycemic shock. Glucose levels were 
measured with a portable glucometer. Only animals with 
fasting glycemia over 300 mg/dL in blood were considered 
diabetic and used for the study. The Ethical Committee of 
Quaid-e-Azam University approved the study protocol for 
animal care and feed (Nagappa et al. 2003).
EXPERIMENTAL DETAILS
Afterwards, the rats were divided into seven groups 
comprising of six animals in each group. Groups I and II 
were normal and diabetic control, group III was standard, 
treated with Glibenclamide (10 mg/kg). Groups IV, V, VI 
and VII were treated with nuciferin, norcoclaurine (10 
mg/kg) and N. nucifera methanolic extract (100-200 mg/
kg), respectively. After 15 days, rats were anesthetized 
and samples were collected for different analyses. For the 
estimation of glucose level in blood and urine, samples 
were collected at days 0, 5, 10 and 15 after treatment with 
plant extract. 
 The level of blood glucose was measured by glucometer 
and the results were compared with standard glibenclamide 
treated group III. For the estimation of biochemical 
parameters blood was collected from retro orbital of each rat 
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and centrifuged at 4000 rpm for 10 min. TG, HDL, LDL, TC, 
urea, alkaline phosphate, creatinine and total protein were 
measured by an auto analyze (Dash et al. 2005; Sharma et 
al. 1997). 
STATISTICAL ANALYSIS
Values are expressed as mean± S.E.M. Data were 
determined statistically significant using student’s t-test. P 
values of less than 0.01 and 0.05 were taken as significant.
RESULTS
The effects of nuciferin, norcoclaurine (10 mg/kg body 
weight/day) and Nelumbo nucifera methanolic extracts 
(MENn) (100-200 mg/kg body weight /day) on blood 
glucose level in alloxan induced diabetic rats are illustrated 
in Table 1 and Figure 1. A marked rise in blood glucose 
level was observed in diabetic group (200.25±1.32 mg/
dL), as compared to normal group (85.65±1.53 mg/
dL) of animals at 15th day. The standard glibenclamide 
(94.55±1.20 mg/dL) and nuciferin (100.10±1.45 mg/dL), 
norcoclaurine (108.80±3.15 mg/dL) as well as Nelumbo 
nucifera methanolic extracts (110.45±1.79 mg/dL) 
significantly decreased the glucose level as compared to 
diabetic group (p<0.05) (Table 1). Hence, findings from 
this study showed that there is a reduction in glucose level 
but the level did not return to that in normal control. There 
is marked reduction in 15 days.
TABLE. 1 Effect of Nelumbo nucifera on blood glucose level in diabetic rats
Treatment Blood glucose level(mg/dL)Day0 Day5 Day10 Day15
Normal control
Diabetic Control
Glibenclamide (10 mg/kg)
Diabetic + MENn (100 mg/kg)
Diabetic + MENn (200 mg/kg)
Diabetic + Nuciferin (10 mg/kg)
Diabetic + Norcoclaurine (10 mg/kg)
95.41±1.65*
255.00±2.85*
200.01±1.85
185.10±2.85
178.00±1.35
198.70±3.85
210.20±4.67
93.27±1.25
235.22±2.32*
156.27±1.68
165.09±1.08
138.5±1.55*
164.10±2.51
170.20±3.25
88.32±0.12
210.55±1.68*
137.36±1.20
134.33±1.03*
120.17±0.97*
142.00±1.23
158.11±1.43
85.65±1.53
200.25±1.32*
94.55±1.20*
120.01±1.9*
110.45±1.79*
100.10±1.45
108.80±3.15
Each value is ±SEM of 5 animals *p<0.05: Normal control vs diabetic control; Diabetic control vs treated groups
Each Value is ±SEM of 5 animals * p< 0.05: Normal control vs diabetic control; Diabetic control vs treated groups. Significant decrease was 
reported as on 15th day by the methanolic extracts 100-1000 mg/kg as compare to standard drug
FIGURE 1. Effect of Nelumbo nucifera on blood glucose level in diabetic rats
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 The effect of nuciferin, norcoclaurine (10 mg/kg) 
and methanolic extract (MENn) (100-200 mg/kg) on 
body weight is summarized in Table 2 and Figure 2. The 
body weight of normal rats was observed to be stable 
(180.25±1.53 g) whereas decrease in weight was observed 
in diabetic rats (148.25±2.52 g). However, the diabetic 
group treated for 15 day with nuciferin (181.120±3.14 
g), norcoclaurine (177.92±1.42 g) and methanolic extract 
(MENn) (178.45±2.79 g) showed significant increase in 
body weight (p<0.05). The body weight was significantly 
recovered 5-10% when examined on 15th day at 100-200 
mg/kg (p<0.05). Marked increase in weight was observed 
in the standard glibenclmide group (14.9%). 
 Table 3 describes the effect of methanolic extract on 
serum profile. Extracts significantly reversed hyperlipidemia 
in diabetic animals as compared to normal. A gradual 
decrease in total cholesterol, low density protein (LDL), 
serum urea, alkaline phosphate, creatinine, triglycerides 
and increase in HDL and serum protein was observed in 
methanolic extract and standard groups. Marked significant 
results was seen using nuciferin and norcoclaurine. Doses 
of 100-200 mg/kg also showed reverse in biochemical 
parameters but not significantly. The main symptom of 
diabetes is frequent and excess production of urine. High 
amount of urine glucose was found in diabetic control 
while treated groups contained no or little glucose in urine. 
No glucose was found in normal control group.
DISCUSSION
The present study is a preliminary assessment of the 
antidiabetic, antihyperglycemic and antihyperlipidemic 
activity of N. nucifera methanolic constituents. Alloxan, 
a highly reactive substance causes a rapid destruction 
of β cells of Langerhans and thus rapidly raises blood 
sugar inducing hyperglycemia. This study suggests that 
nuciferin, norcoclaurine are both potent at reducing 
glucose levels as well as in recovering body weight. 
Administration of the methanolic extract (100-200 
mg/kg b.w.), nuciferin and norcoclaurine (10 mg/kg) 
TABLE 2. Effect of Nelumbo nucifera extract on body weight in diabetic rats
Treatment Body weight variation   (G)Day0 Day5 Day10 Day15
Normal Control
Diabetic Control
Glibenclamide         (10 mg/kg)
Diabetic + MENn    (100 mg/kg)
Diabetic + MENn    (200 mg/kg)
Diabetic + Nuciferin  (10 mg/kg)
Diabetic + Norcoclaurine (10 mg/kg)
180.54±1.55
181.58±1.85*
180.01±1.90
182.10±2.85
178.00±2.75
180.21±4.23
177.33±3.12
178.01±1.35
160.22±1.52*
168.27±2.48
160.00±1.08
162.50±2.55
162.130±2.31
160.51±1.43
177.62±0.12
155.55±2.58*
170.25±2.17*
165.33±1.03*
170.17±0.97*
172.80±2.75
168.71±3.11
180.25±1.53
148.25±2.52*
185.05±1.50*
170.01±1.90*
178.45±2.79*
181.120±3.14
177.92±1.42
Each value is ±SEM of 5 animals * p<0.05: Normal control vs diabetic control; Diabetic control vs treated groups
Each Value is ±SEM of 5 animals * p<0.05: Normal control vs diabetic control; Diabetic control vs treated groups. 
Body weight was significantly recovered 5-10% on 15th day at 100-1000 mg/kg
FIGURE 2. Effect of Nelumbo nucifera on body weight in diabetic rats
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significantly reduced the fasting glucose level of blood 
in alloxan induced diabetic rats as compared to normal 
control. The decline in the body weight observed in the 
diabetic control group may be due to increase uptake of 
muscle glucose. The decline in the body weight observed 
in the diabetic control group was also reported to be 
recovered. However, administration of the antidiabetic 
plant extracts resulted in prevention of tissue loss and 
body weight (Szkudelski 2001; Yadav et al. 2000).
 Alloxan-induced diabetes in rats resulted in weight 
loss due to protein and muscle wasting (Chatterjea & 
Shinde 2002). N. nucifera enhanced body weight of 
diabetic rats in our study due to improvement in metabolic 
activity and maintained normal glucose level. The 
difference in body weights during the treatment with N. 
nucifera were less as compared to the diabetic control. 
The weight improvement is due to glycemic control which 
may be another probable way of antidiabetic action (Maiti 
et al. 2004).
 Elevated plasma triglycerides, low HDL, total 
cholesterol and increased concentration of low LDL 
causes hyperglycemia. The high level of cholesterol 
and triglyceride levels decreased the level of HDL and 
increased the concentration of small dense LDL by 
lipoprotein lipase activation and lecithin acyl-cholesterol 
transferase (Mooradian 2009; Mooradian et al. 2008). 
In the present study, high level of serum TC, TG, LDL 
and decreased HDL cholesterol concentration in alloxan-
induced diabetic mice are in accordance with the previous 
research findings (Howard 1987). However, treatment 
with N. nucifera seed extract normalized all the lipid 
profile parameters.
 Various metabolic alterations occurred in animals due 
to insulin deficiency and thus increased blood glucose 
level, cholesterol level, triglycerides (TG), total protein, 
urine sugar and alkaline phosphate and transaminase. Low 
dose of alloxan (100 mg/kg (b.w.)) causes destruction of 
β cells and even causes permanent diabetes in animals. 
Regeneration is possible in such animals due to surviving 
β cells (Ayber et al. 2008; Prince et al. 2000).
 The major causes of cardiovascular disease in 
diabetic patient are abnormalities in lipid profile. 
Glycemic control is an ideal treatment in controlling 
diabetes. Major coronary risk factors are high level of 
total cholesterol and LDL (Temme et al. 2001). In order 
to prevent cardiac diseases, it was necessary to measure 
biochemical parameters. In this study, N. nucifera 
methanolic extracts showed significant reduction in TC, 
TABLE 3. Effect of Nelumbo nucifera extract on serum profile in diabetic rats
Parameters Normal Control
Diabetic 
control
Glibenclamide 
(10 mg/kg)
Diabetic + 
MENn 
(100 mg/kg)
Diabetic + 
MENn 
(200 mg/kg)
Diabetic + 
Nuciferin 
(10 mg/kg)
Diabetic + 
Norcoclaurine 
(10 mg/kg)
Serum urea (mg/dl) 25.91±0.25 50.25±5.23* 33.01±2.25* 30.27±2.50 31.00±2.15 28.52±1.28* 30.55±2.50*
Serum creatinine 
(mg/dl) 0.85±0.09 2.36±0.1 1.46±0.06 0.42±0.02 1.21±0.05 1.25±0.07* 1.33±0.08*
TC (mg/dl) 51.55±1.09 90.65±1.02* 55.25±1.08* 80.03±1.25 75.19±1.20 60.00±1.10* 57.65±1.03
TG (mg/dl) 84.56±1.01 130.42±1.24 100.46±1.06 120.88±1.15* 109.05±1.04* 104.01±1.12 98.04±1.02*
LDL (mg/dl) 20.45±1.87 58.78±0.62* 23.89±1.35 40.84±1.20 34.23±0.68* 30.73±0.02 25.29±1.54
HDL (mg/dl) 32.5±1.6 28.2±1.2 65.3±1.8* 45.0±1.6* 53.3±1.7* 55.2±1.9* 60.5±1.1*
Plasma Protein (g/dl) 8.11±0.5 6.7±0.01* 7.2±0.4 8.00±0.5 6.90±0.2 6.8±0.1 7.9±0.3
Urine sugar Nil ++ Nil + + Nil  Nil 
Alkaline 
phosphatase (U/L) 120.2±4.0 385±5.6* 125.1±3.7* 165±10.5 162.8±7.2 155.6±6.01 140.03±4.6* 
Each Value is ± SEM of 6 animals * p<0.05 - Normal control vs diabetic control; Diabetic control vs extract groups
FIGURE 3. Nuciferin (1) and norcoclaurine (2) isolated from the seeds of N. nucifera
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TG, LDL, creatinine, alkaline phosphate and urine sugar, 
serum urea levels and high level of HDL and serum protein 
in diabetic rats. However, the elevated HDL and serum 
protein level observed using N. nucifera was comparable 
to the standard drug Glibenclamide. Therefore N. nucifera 
is potentially useful in the prevention of atherosclerosis 
and heart disease (Leontowicz et al. 2002).
CONCLUSION
It was concluded from the results obtained that nuciferin, 
norcoclaurine and crude methanolic extract from N. 
nucifera seeds has dose dependent effect with higher doses 
showing significant antidiabetic activity and decreased 
elevated blood glucose, cholesterol, triglycerides and 
thereby increasing the high density lipoprotein (HDL) levels 
in diabetic rats, hence possess significant antihyperglycemic 
properties in alloxan-induced diabetic rats. N. nucifera may 
be potentially effective against diabetes mellitus. Further 
investigation on this medicinal plant is recommended to 
exploit its hidden medicinal values. The authors declare 
no conflict of interest. 
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